KLP Kapitalforvaltning AS raised its holdings in USANA Health Sciences, Inc. (NYSE:USNA – Free Report) by 373.9% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 10,900 shares of the company’s stock after purchasing an additional 8,600 shares during the quarter. KLP Kapitalforvaltning AS owned 0.06% of USANA Health Sciences worth $294,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Pzena Investment Management LLC boosted its position in shares of USANA Health Sciences by 0.7% during the 1st quarter. Pzena Investment Management LLC now owns 1,095,186 shares of the company’s stock worth $29,537,000 after purchasing an additional 8,110 shares during the period. Dimensional Fund Advisors LP lifted its stake in USANA Health Sciences by 7.7% during the fourth quarter. Dimensional Fund Advisors LP now owns 773,228 shares of the company’s stock worth $27,751,000 after purchasing an additional 55,059 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of USANA Health Sciences by 1.6% during the fourth quarter. Geode Capital Management LLC now owns 301,949 shares of the company’s stock worth $10,839,000 after buying an additional 4,829 shares during the period. American Century Companies Inc. grew its stake in shares of USANA Health Sciences by 12.3% in the fourth quarter. American Century Companies Inc. now owns 233,797 shares of the company’s stock valued at $8,391,000 after buying an additional 25,522 shares in the last quarter. Finally, Northern Trust Corp raised its holdings in shares of USANA Health Sciences by 16.5% in the 4th quarter. Northern Trust Corp now owns 135,937 shares of the company’s stock valued at $4,879,000 after buying an additional 19,266 shares during the period. Hedge funds and other institutional investors own 54.25% of the company’s stock.
Insiders Place Their Bets
In other news, CFO G Doug Iiekking sold 4,548 shares of USANA Health Sciences stock in a transaction dated Friday, May 9th. The stock was sold at an average price of $29.61, for a total value of $134,666.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Walter Noot sold 6,291 shares of the business’s stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $30.29, for a total value of $190,554.39. The disclosure for this sale can be found here. Insiders have sold a total of 15,528 shares of company stock worth $466,513 in the last quarter. 0.63% of the stock is owned by company insiders.
Wall Street Analyst Weigh In
View Our Latest Analysis on USANA Health Sciences
USANA Health Sciences Stock Down 0.4%
Shares of USNA opened at $29.41 on Friday. The company has a market cap of $547.70 million, a P/E ratio of 16.34, a PEG ratio of 0.94 and a beta of 0.64. USANA Health Sciences, Inc. has a fifty-two week low of $23.10 and a fifty-two week high of $45.86. The firm’s 50 day moving average price is $30.91 and its 200 day moving average price is $29.97.
USANA Health Sciences (NYSE:USNA – Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The company reported $0.74 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.20. The business had revenue of $235.85 million for the quarter, compared to analyst estimates of $225.20 million. USANA Health Sciences had a return on equity of 9.48% and a net margin of 3.79%. Research analysts forecast that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current year.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
Read More
- Five stocks we like better than USANA Health Sciences
- What is the Australian Securities Exchange (ASX)
- Golden Cross Alert: 3 Stocks With Serious Upside Potential
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Big Beat, Bigger Plans: AEP Stock Powers Up on Data Center Boom
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Why Byrna Could Be the Top Defense Stock to Watch Now
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.